BIOMARIN PHARMACEUTICAL INC

CUSIP: 09061GAH4 Class: Convertible Debt

SSI INVESTMENT MANAGEMENT LLC's Holding History (CIK: 0000938487)

Note: Option positions (PUT/CALL) are excluded.

Q3 2023
Shares 8,726,000 Value ($000) $8,464 Avg Close — Range —
Q2 2023
Shares 9,386,000 Value ($000) $9,220 Avg Close — Range —
Q1 2023
Shares 14,019,000 Value ($000) $14,383 Avg Close — Range —
Q4 2022
Shares 13,927,000 Value ($000) $14,781 Avg Close — Range —
Q3 2022
Shares 14,257,000 Value ($000) $14,128 Avg Close — Range —
Q2 2022
Shares 11,878,000 Value ($000) $11,761 Avg Close — Range —
Q1 2022
Shares 9,071,000 Value ($000) $9,068 Avg Close — Range —
Q4 2021
Shares 8,944,000 Value ($000) $9,351 Avg Close — Range —
Q1 2021
Shares 444,000 Value ($000) $448 Avg Close — Range —
Q4 2020
Shares 522,000 Value ($000) $559 Avg Close — Range —
Q3 2020
Shares 6,747,000 Value ($000) $7,079 Avg Close — Range —
Q2 2020
Shares 10,695,000 Value ($000) $13,070 Avg Close — Range —
Q1 2020
Shares 6,781,000 Value ($000) $7,058 Avg Close — Range —
Q4 2019
Shares 7,511,000 Value ($000) $7,932 Avg Close — Range —
Q3 2019
Shares 7,035,000 Value ($000) $6,915 Avg Close — Range —
Q2 2019
Shares 7,135,000 Value ($000) $7,407 Avg Close — Range —
Q1 2019
Shares 6,185,000 Value ($000) $6,328 Avg Close — Range —
Q4 2018
Shares 6,245,000 Value ($000) $6,210 Avg Close — Range —
Q3 2018
Shares 6,083,000 Value ($000) $6,421 Avg Close — Range —